C12Y 204/01122
Glycoprotein-n-acetylgalactosamine 3-beta-galactosyltransferase
Official title: Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase (2.4.1.122)
C12Y204/01122 (Glycoprotein-n-acetylgalactosamine 3-beta-galactosyltransferase) appears on 2 US grants and 10 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 10
- Assignees
- 7
- Inventors
- 37
- Latest grant
- 16 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 2 |
| 2024 | 0 | 3 |
| 2025 | 2 | 0 |
| 2026 | 0 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods relating to age-related, neurological, and vascular disease conditions20 Aug 2026US 2026/0241037 A1The Board of Trustees of the Leland Stanford Junior University
- Systems and methods for producing collagen 7 compositions23 Jul 2026US 2026/0209315 A1Phoenix Tissue Repair, Inc.
- Enhancing formation of human milk oligosaccharides (hmos) by modifying lactose import in the cell15 Jan 2026US 2026/0015636 A1Dsm IP Assets B.V.
- Identification of an alpha-1,2-fucosyltransferase for the in vivo production of pure lnfp-i19 Dec 2024US 2024/0417766 A1Dsm IP Assets B.V.
- Enhancing formation of human milk oligosaccharides (hmos) by modifying lactose import in the cell22 Aug 2024US 2024/0279697 A1Dsm IP Assets B.V.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.